Lavipharm S.A. (LAVI.AT)
EUR 0.75
(-1.7%)
EUR 0.75
(-1.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 50.92 Million | 39.05 Million | 39.72 Million | 37.63 Million | 33.58 Million | 31.79 Million |
| Cost of Revenue | 27.73 Million | 22.67 Million | 25.03 Million | 22.53 Million | 18.64 Million | 17.04 Million |
| Gross Profit | 23.19 Million | 16.37 Million | 14.69 Million | 15.1 Million | 14.94 Million | 14.74 Million |
| Operating Expenses | 18.13 Million | 13.68 Million | 15.09 Million | 13.14 Million | 14.07 Million | 15.11 Million |
| Selling, General and Administrative Expenses | 18.35 Million | 14.56 Million | 14.2 Million | 12.26 Million | 13.31 Million | 14.28 Million |
| Research and Development Expenses | 430 Thousand | 365 Thousand | 342 Thousand | 302 Thousand | 290 Thousand | 410 Thousand |
| Other Expenses | -648 Thousand | 1.24 Million | -548 Thousand | -573 Thousand | -469 Thousand | -420 Thousand |
| Cost and Expenses | 46.93 Million | 36.36 Million | 40.12 Million | 35.68 Million | 32.71 Million | 32.16 Million |
| Operating Income | 3.99 Million | 2.69 Million | -398 Thousand | 1.95 Million | 876 Thousand | -370 Thousand |
| Interest Expense | 2.26 Million | 1.64 Million | 1.83 Million | 1.92 Million | 1.92 Million | 1.92 Million |
| Income Tax Expense | 1.25 Million | 1.3 Million | 1.01 Million | 1.21 Million | -3.21 Million | 1.61 Million |
| Earnings before Tax | 3.24 Million | 2.25 Million | 2.74 Million | 3.3 Million | 2.11 Million | 2.86 Million |
| Net Income | 1.87 Million | 834 Thousand | 1.72 Million | 2.09 Million | 5.32 Million | 1.24 Million |
| Earnings Per Share Basic | 0.01 | 0.04 | 0.09 | 0.11 | 0.29 | 0.07 |
| Earnings Per Share Diluted | 0.01 | 0.04 | 0.09 | 0.11 | 0.29 | 0.07 |
| Weighted Average Shares Outstanding | 167.86 Million | 21.52 Million | 18.29 Million | 18.29 Million | 18.29 Million | 18.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 168.2 Million | 21.52 Million | 18.29 Million | 18.29 Million | 18.29 Million | 18.29 Million |
| Gross Margin | 0.46 | 0.42 | 0.37 | 0.40 | 0.45 | 0.46 |
| EBIT Margin | 0.19 | 0.11 | 0.03 | 0.09 | 0.07 | 0.03 |
| Profit Margin | 0.04 | 0.02 | 0.04 | 0.06 | 0.16 | 0.04 |
| EBITDA | 9.86 Million | 5.6 Million | 6.23 Million | 6.79 Million | 5.46 Million | 3.76 Million |
| Earnings Before Tax Margin | 0.08 | 0.07 | -0.01 | 0.05 | 0.03 | -0.01 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 26.3 Million | 21.47 Million | 50.92 Million | 29.45 Million | 39.05 Million | 24.8 Million |
| Cost of Revenue | 14.76 Million | 11 Million | 28.79 Million | 17.79 Million | 22.67 Million | 16.05 Million |
| Gross Profit | 11.54 Million | 10.46 Million | 22.13 Million | 11.66 Million | 16.37 Million | 8.75 Million |
| Operating Expenses | 9.34 Million | 10.03 Million | 18.13 Million | 8.09 Million | 13.68 Million | 8.32 Million |
| Selling, General and Administrative Expenses | 9.3 Million | 10.12 Million | - | 8.23 Million | - | 7.94 Million |
| Research and Development Expenses | 127 Thousand | 132 Thousand | - | 63 Thousand | - | 199 Thousand |
| Other Expenses | 85 Thousand | 213 Thousand | 413 Thousand | 200 Thousand | 1.24 Million | -181.99 Thousand |
| Cost and Expenses | 24.1 Million | 21.04 Million | 46.93 Million | 25.88 Million | 36.36 Million | 24.38 Million |
| Operating Income | 2.2 Million | 426 Thousand | 3.99 Million | 3.56 Million | 2.69 Million | 429 Thousand |
| Interest Expense | 1.1 Million | 1.08 Million | 2.26 Million | 1.18 Million | 1.64 Million | 909 Thousand |
| Income Tax Expense | -4.97 Million | 610 Thousand | 1.25 Million | 641 Thousand | 1.3 Million | 1.09 Million |
| Earnings before Tax | 2.43 Million | 388 Thousand | 3.24 Million | 2.85 Million | 2.25 Million | 32 Thousand |
| Net Income | 7.74 Million | -347 Thousand | 1.87 Million | 2.21 Million | 834 Thousand | -1.06 Million |
| Earnings Per Share Basic | 0.05 | -0.00 | - | 0.01 | - | -0.01 |
| Earnings Per Share Diluted | 0.05 | -0.00 | - | 0.01 | - | -0.01 |
| Weighted Average Shares Outstanding | 167.86 Million | 167.86 Million | 167.86 Million | 167.86 Million | 21.52 Million | 167.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 168.64 Million | 167.86 Million | 168.2 Million | 167.86 Million | 21.52 Million | 167.86 Million |
| Gross Margin | 0.44 | 0.49 | 0.43 | 0.40 | 0.42 | 0.35 |
| EBIT Margin | 0.22 | 0.12 | - | 0.20 | - | 0.05 |
| Profit Margin | 0.29 | -0.02 | 0.04 | 0.08 | 0.02 | -0.04 |
| EBITDA | 5.68 Million | 2.58 Million | - | 5.76 Million | - | 1.32 Million |
| Earnings Before Tax Margin | 0.08 | 0.02 | 0.08 | 0.12 | 0.07 | 0.02 |
300345
BTAFF
6806
CTPNV
2327
UCASU